Logo image
Evaluation of a positive marker of avian influenza vaccination in ducks for use in H5N1 surveillance
Journal article   Open access   Peer reviewed

Evaluation of a positive marker of avian influenza vaccination in ducks for use in H5N1 surveillance

C.M. James-Berry, Y.Y. Foong, J.P. Mansfield, A.R. Vind, S.G. Fenwick and T.M. Ellis
Vaccine, Vol.26(42), pp.5345-5351
2008
pdf
evaluation_of_a_positive_marker_of_avian_influenza_vaccination.pdfDownloadView
Author’s Version Open Access
url
Link to Published Version *Subscription may be requiredView

Abstract

Control measures for H5N1 avian influenza involve increased biosecurity, monitoring, surveillance and vaccination. Subclinical infection in farmed ducks is important for virus persistence. In major duck rearing countries, homologous H5N1 vaccines are being used in ducks, so sero-surveillance using H5- or N1-specific antibody testing cannot identify infected flocks. An alternative is to include apositivemarker for vaccination. Testing for an antibody response to the marker would confirm approved vaccine use. Concurrent testing for H5 antibody responses would determine levels adequate for protection or indicate recent infection, with an anamnestic H5 antibody response requiring further virological investigation. In this study, we have evaluated the use of a TT marker in ducks given avian influenza vaccination. Wild or domestic ducks were tested for antibodies against TT and all 463 ducks were negative. High levels of TT-specific antibodies, produced in twice-TT vaccinated Muscovy ducks, persisted out to 19 weeks. There was no interference by inclusion of TT in an inactivated H6N2 vaccine for H6- or TT-seroconversion. Thus TT is a highly suitable exogenous marker for avianinfluenzavaccination in ducks and allows sero-surveillance in countries using H5N 1vaccination.

Details

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Metrics

242 File views/ downloads
47 Record Views

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Citation topics
1 Clinical & Life Sciences
1.104 Virology - General
1.104.126 Influenza
Web Of Science research areas
Immunology
Medicine, Research & Experimental
ESI research areas
Immunology
Logo image